0.55 -0.03 (-5.17%)

New 52W Low today

1.2M XNAS Volume

High volume+loss today

XNAS 20 Mar, 2025 5:30 PM (EDT)

Board Meeting
The board meeting for Century Therapeutics Inc is scheduled for today, for the purpose of Century Therapeutics Inc Fourth Quarter Earnings Results for 2024 See details


Insider Trading disclosures for Century Therapeutics Inc

The latest disclosure was made by Morgan Conn in Century Therapeutics Inc where a trade of 19,500 Common Stock done was reported to US exchanges on March 11, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Morgan Conn Chief Finanical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2025 19,500 79,648 - 0 Common Stock
Morgan Conn Chief Finanical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2025 19,500 19,500 - - Stock Option (right to buy)
Chad Cowan Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2025 19,500 19,500 - - Stock Option (right to buy)
Chad Cowan Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2025 19,500 230,306 - 0 Common Stock
Adrienne Farid Chief Operations Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2025 120,000 251,717 - 0 Common Stock
Adrienne Farid Chief Operations Officer Sale of securities on an exchange or to another person at price $ 0.62 per share. 10 Mar 2025 2,359 131,717 - 0.6 1,451 Common Stock
Adrienne Farid Chief Operations Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2025 120,000 120,000 - - Stock Option (right to buy)
Gregory Russotti See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2025 120,000 392,573 - 0 Common Stock
Gregory Russotti See Remarks Sale of securities on an exchange or to another person at price $ 0.61 per share. 10 Mar 2025 2,360 272,573 - 0.6 1,451 Common Stock
Gregory Russotti See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2025 120,000 120,000 - - Stock Option (right to buy)
Douglas Carr SVP Finance & Operations Sale of securities on an exchange or to another person at price $ 0.62 per share. 10 Mar 2025 1,240 315,556 - 0.6 763 Common Stock
Douglas Carr SVP Finance & Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2025 95,625 95,625 - - Stock Option (right to buy)
Douglas Carr SVP Finance & Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2025 95,625 411,181 - 0 Common Stock
Brent Pfeiffenberger Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.62 per share. 10 Mar 2025 2,235 1,190,310 - 0.6 1,375 Common Stock
Brent Pfeiffenberger Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2025 521,500 1,711,810 - 0 Common Stock
Brent Pfeiffenberger Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2025 521,500 521,500 - - Stock Option (right to buy)
Brent Pfeiffenberger Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.78 per share. 18 Feb 2025 34,712 1,192,545 - 0.8 27,179 Common Stock
Adrienne Farid Chief Operations Officer Sale of securities on an exchange or to another person at price $ 0.78 per share. 03 Feb 2025 1,054 134,076 - 0.8 822 Common Stock
Douglas Carr SVP Finance & Operations Sale of securities on an exchange or to another person at price $ 0.78 per share. 03 Feb 2025 351 316,796 - 0.8 274 Common Stock
Brent Pfeiffenberger Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.44 per share. 04 Dec 2024 243,447 1,227,257 - 1.4 350,564 Common Stock
Adrienne Farid Chief Operations Officer Sale of securities on an exchange or to another person at price $ 1.23 per share. 04 Nov 2024 1,033 135,130 - 1.2 1,267 Common Stock
Douglas Carr SVP Finance & Operations Sale of securities on an exchange or to another person at price $ 1.23 per share. 01 Nov 2024 283 317,147 - 1.2 347 Common Stock
Douglas Carr SVP Finance & Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.26 per share. 01 Nov 2024 16,611 317,430 - 1.3 20,930 Common Stock
Morgan Conn Chief Finanical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Oct 2024 60,148 60,148 - 0 Common Stock
Morgan Conn Chief Finanical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Oct 2024 360,890 360,890 - - Stock Option (right to buy)
Chad Cowan Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2024 446,250 446,250 - - Stock Option (right to buy)
Chad Cowan Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2024 74,376 210,806 - 0 Common Stock
Daphne Quimi Director Purchase of securities on an exchange or from another person at price $ 1.53 per share. 12 Sep 2024 5,000 5,000 - 1.5 7,657 Common Stock
Adrienne Farid Chief Operations Officer Sale of securities on an exchange or to another person at price $ 1.83 per share. 05 Aug 2024 1,073 136,163 - 1.8 1,960 Common Stock
Douglas Carr SVP Finance & Operations Sale of securities on an exchange or to another person at price $ 1.83 per share. 05 Aug 2024 289 334,041 - 1.8 528 Common Stock
Gregory Russotti See Remarks Sale of securities on an exchange or to another person at price $ 2.50 per share. 26 Jul 2024 586 274,933 - 2.5 1,465 Common Stock
Gregory Russotti See Remarks Sale of securities on an exchange or to another person at price $ 2.52 per share. 23 Jul 2024 1,600 275,519 - 2.5 4,029 Common Stock
Gregory Russotti See Remarks Sale of securities on an exchange or to another person at price $ 2.50 per share. 23 Jul 2024 200 277,119 - 2.5 500 Common Stock
Cynthia M. Butitta Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 44,000 44,000 - - Stock Option (right to buy)
Joseph Jimenez Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 44,000 44,000 - - Stock Option (right to buy)
Timothy P. Walbert Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 44,000 44,000 - - Stock Option (right to buy)
Daphne Quimi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 44,000 44,000 - - Stock Option (right to buy)
Kimberly L. Blackwell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 44,000 44,000 - - Stock Option (right to buy)
Carlo Rizzuto Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 44,000 44,000 - - Stock Option (right to buy)
Alessandro Riva Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 44,000 44,000 - - Stock Option (right to buy)
Gregory Russotti See Remarks Sale of securities on an exchange or to another person at price $ 2.84 per share. 20 Jun 2024 5,000 277,319 - 2.8 14,179 Common Stock
Douglas Carr SVP Finance & Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2024 17,007 334,330 - 0 Common Stock
Gregory Russotti See Remarks Sale of securities on an exchange or to another person at price $ 3.00 per share. 05 Jun 2024 5,000 282,319 - 3.0 14,989 Common Stock
Gregory Russotti See Remarks Sale of securities on an exchange or to another person at price $ 3.00 per share. 20 May 2024 5,000 287,319 - 3.0 14,978 Common Stock
Gregory Russotti See Remarks Sale of securities on an exchange or to another person at price $ 3.12 per share. 06 May 2024 5,000 292,319 - 3.1 15,619 Common Stock
Adrienne Farid Chief Operations Officer Sale of securities on an exchange or to another person at price $ 3.11 per share. 03 May 2024 913 137,236 - 3.1 2,836 Common Stock
Douglas Carr SVP Finance & Operations Sale of securities on an exchange or to another person at price $ 3.11 per share. 03 May 2024 257 317,323 - 3.1 798 Common Stock
Gregory Russotti See Remarks Sale of securities on an exchange or to another person at price $ 3.10 per share. 22 Apr 2024 5,000 297,319 - 3.1 15,490 Common Stock
Hyam I. Levitsky President of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 146,000 146,000 - - Stock Option (right to buy)
Hyam I. Levitsky President of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 24,000 24,000 - 0 Common Stock
Adrienne Farid Chief Operations Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 24,000 138,149 - 0 Common Stock
Adrienne Farid Chief Operations Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 146,000 146,000 - - Stock Option (right to buy)
Gregory Russotti See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 24,000 302,319 - 0 Common Stock
Gregory Russotti See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 146,000 146,000 - - Stock Option (right to buy)
Douglas Carr SVP Finance & Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 14,000 317,580 - 0 Common Stock
Douglas Carr SVP Finance & Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 81,000 81,000 - - Stock Option (right to buy)
Brent Pfeiffenberger Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 17,425 1,470,704 - 0 Common Stock
Brent Pfeiffenberger Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 104,550 104,550 - - Stock Option (right to buy)
Adrienne Farid Chief Operations Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. 06 Mar 2024 22,831 136,980 - 1.0 23,516 Common Stock
Adrienne Farid Chief Operations Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. 06 Mar 2024 30,684 144,833 - 1.0 31,605 Common Stock
Adrienne Farid Chief Operations Officer Sale of securities on an exchange or to another person at price $ 4.96 per share. 06 Mar 2024 30,684 114,149 - 5.0 152,340 Common Stock
Adrienne Farid Chief Operations Officer Sale of securities on an exchange or to another person at price $ 5.14 per share. 06 Mar 2024 22,831 114,149 - 5.1 117,342 Common Stock
Adrienne Farid Chief Operations Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2024 22,831 168,655 - - Stock Option (right to buy)
Adrienne Farid Chief Operations Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2024 30,684 191,486 - - Stock Option (right to buy)
Farid Adrienne Chief Operations Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Feb 2024 485 222,170 - - Stock Option (right to buy)
Adrienne Farid Chief Operations Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. 16 Feb 2024 485 114,634 - 1.0 500 Common Stock
Adrienne Farid Chief Operations Officer Sale of securities on an exchange or to another person at price $ 4.86 per share. 16 Feb 2024 485 114,149 - 4.9 2,358 Common Stock
Carr Douglas SVP Finance & Operations Sale of securities on an exchange or to another person at price $ 3.84 per share. 05 Feb 2024 643 304,137 - 3.8 2,470 Common Stock
Douglas Carr SVP Finance & Operations Sale of securities on an exchange or to another person at price $ 4.49 per share. 05 Feb 2024 557 303,580 - 4.5 2,499 Common Stock
Farid Adrienne Chief Operations Officer Sale of securities on an exchange or to another person at price $ 3.84 per share. 05 Feb 2024 2,035 115,933 - 3.8 7,816 Common Stock
Adrienne Farid Chief Operations Officer Sale of securities on an exchange or to another person at price $ 4.49 per share. 05 Feb 2024 1,784 114,149 - 4.5 8,005 Common Stock
Brent Pfeiffenberger Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Dec 2023 573,691 573,691 - - Stock Option (right to buy)
Brent Pfeiffenberger Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Dec 2023 279,504 1,453,279 - 0 Common Stock
Pfeiffenberger Brent Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Dec 2023 1,173,775 1,173,775 - 0 Common Stock
Cynthia M. Butitta Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2023 44,000 44,000 - - Stock Option (right to buy)
Joseph Jimenez Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2023 44,000 44,000 - - Stock Option (right to buy)
Timothy P. Walbert Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2023 44,000 44,000 - - Stock Option (right to buy)
Daphne Quimi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2023 44,000 44,000 - - Stock Option (right to buy)
Kimberly Blackwell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2023 44,000 44,000 - - Stock Option (right to buy)
Carlo Rizzuto Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2023 44,000 44,000 - - Stock Option (right to buy)
Alessandro Riva Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2023 44,000 44,000 - - Stock Option (right to buy)
Michael Diem Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2023 151,058 274,296 - 0 Common Stock
Douglas Carr SVP Finance & Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2023 120,846 321,391 - 0 Common Stock
Gregory Russotti Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Apr 2023 318,750 318,750 - - Stock Option (right to buy)
Luis Borges Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Apr 2023 7,452 0 - - Stock Option (right to buy)
Luis Borges Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. 03 Apr 2023 7,452 256,535 - 1.0 7,676 Common Stock
Luis Borges Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 3.55 per share. 21 Mar 2023 15,597 249,083 - 3.5 55,369 Common Stock
Luis Borges Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. 21 Mar 2023 63,616 107,366 - 1.0 65,524 Common Stock
Luis Borges Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 3.77 per share. 21 Mar 2023 63,616 43,750 - 3.8 239,870 Common Stock
Luis Borges Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. 21 Mar 2023 65,698 109,448 - 1.0 67,669 Common Stock
Luis Borges Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 3.72 per share. 21 Mar 2023 65,698 43,750 - 3.7 244,640 Common Stock
Luis Borges Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. 21 Mar 2023 220,930 264,680 - 1.0 227,558 Common Stock
Luis Borges Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Mar 2023 63,616 294,080 - - Stock Option (right to buy)
Luis Borges Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Mar 2023 65,698 228,382 - - Stock Option (right to buy)
Luis Borges Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Mar 2023 220,930 7,452 - - Stock Option (right to buy)
Michael Diem Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 131,250 131,250 - - Stock Option (right to buy)
Michael Diem Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 131,250 131,250 - - Stock Option (right to buy)
Michael Diem Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 21,875 123,238 - 0 Common Stock
Michael Diem Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 21,875 101,363 - 0 Common Stock
Luis Borges Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 21,875 43,750 - 0 Common Stock
Luis Borges Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 131,250 131,250 - - Stock Option (right to buy)
Luis Borges Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 131,250 131,250 - - Stock Option (right to buy)
Luis Borges Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 21,875 21,875 - 0 Common Stock
Osvaldo Flores Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 637,500 637,500 - - Stock Option (right to buy)
Osvaldo Flores Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 637,500 637,500 - - Stock Option (right to buy)
Adrienne Farid Chief Operations Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 131,250 131,250 - - Stock Option (right to buy)
Adrienne Farid Chief Operations Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 21,875 96,093 - 0 Common Stock
Adrienne Farid Chief Operations Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 21,875 117,968 - 0 Common Stock
Adrienne Farid Chief Operations Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 131,250 131,250 - - Stock Option (right to buy)
Gregory Russotti Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 175,000 175,000 - - Stock Option (right to buy)
Gregory Russotti Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 175,000 175,000 - - Stock Option (right to buy)
Douglas Carr VP Finance & Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 7,500 200,545 - 0 Common Stock
Douglas Carr VP Finance & Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 45,000 45,000 - - Stock Option (right to buy)
Douglas Carr VP Finance & Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 45,000 45,000 - - Stock Option (right to buy)
Douglas Carr VP Finance & Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 7,500 193,045 - 0 Common Stock
Timothy P. Walbert Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2022 39,744 39,744 - - Stock Option (right to buy)
Daphne Quimi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2022 39,744 39,744 - - Stock Option (right to buy)
Cynthia M. Butitta Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,872 19,872 - - Stock Option (right to buy)
Joseph Jimenez Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,872 19,872 - - Stock Option (right to buy)
Eli D. Casdin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,872 19,872 - - Stock Option (right to buy)
Kimberly Blackwell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,872 19,872 - - Stock Option (right to buy)
Carlo Rizzuto Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,872 19,872 - - Stock Option (right to buy)
Alessandro Riva Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,872 19,872 - - Stock Option (right to buy)
Hyam I. Levitsky President of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2022 105,000 105,000 - - Stock Option (right to buy)
Michael Diem Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2022 105,000 105,000 - - Stock Option (right to buy)
Luis Borges Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2022 105,000 105,000 - - Stock Option (right to buy)
Osvaldo Flores Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2022 315,000 315,000 - - Stock Option (right to buy)
Adrienne Farid Chief Operations Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2022 105,000 105,000 - - Stock Option (right to buy)
Gregory Russotti Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2022 105,000 105,000 - - Stock Option (right to buy)
Douglas Carr VP of Finance and Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2022 35,000 35,000 - - Stock Option (right to buy)
Eli Casdin Director 22 Jun 2021 6,180,500 0 - - Series C Preferred Stock
Eli Casdin Director Purchase of securities on an exchange or from another person at price $ 20.00 per share. 22 Jun 2021 750,000 3,206,380 - 20 15,000,000 Common Stock
Eli Casdin Director 22 Jun 2021 2,456,380 2,456,380 - - Common Stock
Cynthia M. Butitta Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 19,872 19,872 - - Option (right to buy)
Joseph Jimenez Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 19,872 19,872 - - Option (right to buy)
Eli Casdin Director Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jun 2021 39,744 39,744 - - Option (right to buy)
Kimberly Blackwell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 19,872 19,872 - - Option (right to buy)
Carlo Rizzuto Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 39,744 39,744 - - Option (right to buy)
Alessandro Riva Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 19,872 19,872 - - Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures